Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 32
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AlzChem Group AG (ACT1)
AlzChem Group AG stock price live, this page displays F ACT1 stock exchange data. View the ACT1 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AlzChem Group AG real time stock price chart below.
What Is the AlzChem Group AG Stock Price Today?
The AlzChem Group AG stock price today is 60.80.
What Is the Stock Symbol for AlzChem Group AG?
The stock symbol for AlzChem Group AG is "ACT1."
What Stock Exchange Does AlzChem Group AG Trade On?
AlzChem Group AG is listed and trades on the Frankfurt stock exchange.
Is AlzChem Group AG a Good Stock to Buy?
Determining whether AlzChem Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACT1 quote. (ISIN: DE000A2YNT30)
What Is the AlzChem Group AG Stock Price Today?
The AlzChem Group AG stock price today is 60.80.
What Is the Stock Symbol for AlzChem Group AG?
The stock symbol for AlzChem Group AG is "ACT1."
What Stock Exchange Does AlzChem Group AG Trade On?
AlzChem Group AG is listed and trades on the Frankfurt stock exchange.
Is AlzChem Group AG a Good Stock to Buy?
Determining whether AlzChem Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACT1 quote. (ISIN: DE000A2YNT30)
60.80
0.00(0.00%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.80
60.80
52 wk Range
22.40
67.00
ACT1 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.8060.80
52 wk Range
22.4067.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ACT1 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
- Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 32
AlzChem Group AG Company Profile
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany.
Compare ACT1 to Peers and Sector
Metrics to compare | ACT1 | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipACT1PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.3x | 16.9x | −0.1x | |
PEG Ratio | 0.19 | 0.26 | 0.00 | |
Price/Book | 3.2x | 1.1x | 1.6x | |
Price / LTM Sales | 1.1x | 0.6x | 1.2x | |
Upside (Analyst Target) | 22.3% | 17.7% | 30.2% | |
Fair Value Upside | Unlock | 14.9% | 2.9% | Unlock |
Earnings
Latest Release
Nov 07, 2024
EPS / Forecast
1.22 / --
Revenue / Forecast
128.94M / 128.91M
People Also Watch
FAQ
What Is the AlzChem Group (ACT1) Stock Price Today?
The AlzChem Group stock price today is 60.80
What Stock Exchange Does AlzChem Group Trade On?
AlzChem Group is listed and trades on the Frankfurt stock exchange.
What Is the Stock Symbol for AlzChem Group?
The stock symbol for AlzChem Group is "ACT1."
Does AlzChem Group Pay Dividends? What’s The Current Dividend Yield?
The AlzChem Group dividend yield is 1.97%.
What Is the AlzChem Group Market Cap?
As of today, AlzChem Group market cap is 618.72M.
What is AlzChem Group Earnings Per Share?
The AlzChem Group EPS is 4.93.
What Is the Next AlzChem Group Earnings Date?
AlzChem Group will release its next earnings report on 27 Feb 2025.
From a Technical Analysis Perspective, Is ACT1 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.